Article
Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion.
The British journal of ophthalmology - 1 Nov 2001
Boyd S, Owens D, Gin T, Bunce K, Sherafat H, Perry D, Hykin P G
Abstract excerpt
AIMS: To determine whether plasma homocysteine, methylene tetrahydrofolate reductase (MTHFR) C677T and factor II G20210A polymorphisms, factor VIII, and vWF are risk factors for central retinal vein occlusion (CRVO). METHOD: Prospective comparison of 63 consecutive patients with central retinal vein occlusion and 63 age matched controls. Plasma homocysteine and vWF were estimated by ELISA, the MTFHR and factor II...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.